Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double blind, placebo controlled, parallel group study is to
compare the safety and efficacy of topically applied DS107 cream (1% and 5%) versus vehicle
cream, in the treatment of adult patients with mild to moderate Atopic Dermatitis.